JP2016532457A5 - - Google Patents

Download PDF

Info

Publication number
JP2016532457A5
JP2016532457A5 JP2016547976A JP2016547976A JP2016532457A5 JP 2016532457 A5 JP2016532457 A5 JP 2016532457A5 JP 2016547976 A JP2016547976 A JP 2016547976A JP 2016547976 A JP2016547976 A JP 2016547976A JP 2016532457 A5 JP2016532457 A5 JP 2016532457A5
Authority
JP
Japan
Prior art keywords
cells
cell culture
cell
interest
metabolic shift
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016547976A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016532457A (ja
JP6663854B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059993 external-priority patent/WO2015054554A1/en
Publication of JP2016532457A publication Critical patent/JP2016532457A/ja
Publication of JP2016532457A5 publication Critical patent/JP2016532457A5/ja
Priority to JP2020024484A priority Critical patent/JP6967620B2/ja
Application granted granted Critical
Publication of JP6663854B2 publication Critical patent/JP6663854B2/ja
Priority to JP2021173755A priority patent/JP7377243B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016547976A 2013-10-11 2014-10-10 代謝が最適化された細胞培養 Active JP6663854B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2020024484A JP6967620B2 (ja) 2013-10-11 2020-02-17 代謝が最適化された細胞培養
JP2021173755A JP7377243B2 (ja) 2013-10-11 2021-10-25 代謝が最適化された細胞培養

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361889815P 2013-10-11 2013-10-11
US61/889,815 2013-10-11
PCT/US2014/059993 WO2015054554A1 (en) 2013-10-11 2014-10-10 Metabolically optimized cell culture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020024484A Division JP6967620B2 (ja) 2013-10-11 2020-02-17 代謝が最適化された細胞培養

Publications (3)

Publication Number Publication Date
JP2016532457A JP2016532457A (ja) 2016-10-20
JP2016532457A5 true JP2016532457A5 (enExample) 2017-11-09
JP6663854B2 JP6663854B2 (ja) 2020-03-13

Family

ID=52813657

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016547976A Active JP6663854B2 (ja) 2013-10-11 2014-10-10 代謝が最適化された細胞培養
JP2020024484A Active JP6967620B2 (ja) 2013-10-11 2020-02-17 代謝が最適化された細胞培養
JP2021173755A Active JP7377243B2 (ja) 2013-10-11 2021-10-25 代謝が最適化された細胞培養

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020024484A Active JP6967620B2 (ja) 2013-10-11 2020-02-17 代謝が最適化された細胞培養
JP2021173755A Active JP7377243B2 (ja) 2013-10-11 2021-10-25 代謝が最適化された細胞培養

Country Status (18)

Country Link
US (2) US20160244725A1 (enExample)
EP (3) EP3351620B1 (enExample)
JP (3) JP6663854B2 (enExample)
KR (4) KR102358807B1 (enExample)
CN (2) CN105637085A (enExample)
AU (2) AU2014331776B2 (enExample)
CA (1) CA2926049C (enExample)
DK (3) DK3351620T3 (enExample)
EA (2) EA033783B1 (enExample)
ES (2) ES2833471T3 (enExample)
FI (1) FI3812453T3 (enExample)
HU (2) HUE039551T2 (enExample)
IL (2) IL244511A0 (enExample)
MX (2) MX384960B (enExample)
PL (2) PL3351620T3 (enExample)
SG (2) SG10201800772TA (enExample)
WO (1) WO2015054554A1 (enExample)
ZA (1) ZA201601550B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
DK3351620T3 (da) 2013-10-11 2020-10-26 Regeneron Pharma Metabolsk optimeret cellekultur
US20160244726A1 (en) * 2013-10-11 2016-08-25 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
JP7260011B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260018B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260020B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7310947B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7260009B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260021B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7310945B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7310952B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7260012B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7272480B2 (ja) * 2017-04-27 2023-05-12 株式会社三洋物産 遊技機
JP7260013B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
EP3692358A1 (en) 2017-10-06 2020-08-12 Lonza Ltd Automated control of cell culture using raman spectroscopy
SG11202002339XA (en) 2017-10-16 2020-04-29 Regeneron Pharma Perfusion bioreactor and related methods of use
JP7471220B2 (ja) * 2017-11-30 2024-04-19 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト 哺乳動物細胞の培養方法
JP2021519073A (ja) * 2018-03-29 2021-08-10 ジェネンテック, インコーポレイテッド 哺乳動物細胞におけるラクトジェニック活性の制御
GB201810772D0 (en) * 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
JP7231355B2 (ja) * 2018-08-22 2023-03-01 日機装株式会社 細胞培養方法および細胞培養装置
CN120795059A (zh) 2018-08-27 2025-10-17 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
KR102559149B1 (ko) 2018-10-26 2023-07-24 에프. 호프만-라 로슈 아게 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
JP2020151560A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
JP2020151559A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
EP3985097A1 (en) * 2020-10-14 2022-04-20 Sartorius Stedim Biotech GmbH A method and system for configuring and/or setup of a downstream process for processing a biomass

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
KR970029803A (ko) 1995-11-03 1997-06-26 김광호 반도체 메모리장치의 프리차지 회로
US6165741A (en) 1997-05-30 2000-12-26 The Trustees Of The University Of Pennsylvania Method for rapid detection of bacterial growth in cultures
US5972650A (en) 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
WO2002057423A2 (en) 2001-01-16 2002-07-25 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US7039770B1 (en) 2002-03-05 2006-05-02 Juniper Networks, Inc. Low latency request dispatcher
CA2417689C (en) 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Improved methods for growing mammalian cells in vitro
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
US7429491B2 (en) 2003-05-15 2008-09-30 Wyeth Restricted glucose feed for animal cell culture
US7531327B2 (en) * 2004-07-23 2009-05-12 Immunomedics, Inc. Methods and compositions for increasing longevity and protein yield from a cell culture
TWI374935B (en) 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
US7300773B2 (en) * 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
AU2006312014A1 (en) * 2005-11-02 2007-05-18 Wyeth Methods for adapting mammalian cells
US10155816B2 (en) 2005-11-28 2018-12-18 Genmab A/S Recombinant monovalent antibodies and methods for production thereof
US7575890B2 (en) 2006-01-18 2009-08-18 Oxygen Enterprises, Ltd. Method for rapid detection and evaluation of cultured cell growth
US8192951B2 (en) 2006-11-03 2012-06-05 Wyeth Llc Glycolysis-inhibiting substances in cell culture
WO2008151219A1 (en) 2007-06-04 2008-12-11 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
EP2188371B1 (en) 2007-08-09 2017-12-20 Wyeth LLC Use of perfusion to enhance production of fed-batch cell culture in bioreactors
WO2009152413A1 (en) * 2008-06-13 2009-12-17 Centocor Ortho Biotech Inc. Methods for obtaining high viable cell density in mammalian cell culture
US8470552B2 (en) * 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
PT2563904E (pt) * 2010-04-26 2015-05-12 Novartis Ag Meio de cultura de células aperfeiçoado
WO2011150241A2 (en) * 2010-05-28 2011-12-01 Genentech, Inc. Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
US20140199728A1 (en) * 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
DK3351620T3 (da) 2013-10-11 2020-10-26 Regeneron Pharma Metabolsk optimeret cellekultur

Similar Documents

Publication Publication Date Title
Zeltz et al. α11β1 integrin is induced in a subset of cancer-associated fibroblasts in desmoplastic tumor stroma and mediates in vitro cell migration
Jabalee et al. The role of extracellular vesicles in cancer: cargo, function, and therapeutic implications
Golubovskaya et al. CD47-CAR-T cells effectively kill target cancer cells and block pancreatic tumor growth
Roato et al. Cancer stem cells, bone and tumor microenvironment: key players in bone metastases
FI3812453T3 (fi) Metabolisesti optimoitu soluviljelmä
HRP20211882T1 (hr) Protutijela protiv cd40 i njihova upotreba
HRP20220081T1 (hr) Bcma i cd3 bispecifična t stanica koja uključuje konstrukte protutijela
HRP20191409T1 (hr) Postupci i sredstva za proizvodnju heterodimernih ig-sličnih molekula
Laroute et al. Environmental conditions affecting GABA production in Lactococcus lactis NCDO 2118
JP2018514204A5 (enExample)
RU2018113510A (ru) Химерные рецепторы антигена, нацеленные на psca
IL292650B2 (en) COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13Ra2
JP2016196468A5 (enExample)
GB2549632A8 (en) Fusion protein comprising three binding domains to 5T4 and CD3
JP2014534207A5 (enExample)
FI3390442T3 (fi) Anti-C5-vasta-aineita ja käyttömenetelmiä
Hengelbrock et al. Digital twin for HIV-gag VLP production in HEK293 cells
Wang et al. Genome-wide identification and expression analysis of MAPK gene family in lettuce (Lactuca sativa L.) and functional analysis of LsMAPK4 in high-temperature-induced bolting
Ehlers et al. ADCC-inducing antibody trastuzumab and selection of KIR-HLA ligand mismatched donors enhance the NK cell anti-breast cancer response
EP2534099A4 (en) SYSTEM AND METHOD FOR PRODUCING RENEWABLE RESOURCES, SUCH AS HYDROGEN BY MICROBIAL ELECTROLYSIS, FERMENTATION AND / OR PHOTOSYNTHESIS
Piñeiro-Ramil et al. Generation of mesenchymal cell lines derived from aged donors
JP2013531967A5 (enExample)
Chalenko et al. Natural isoforms of Listeria monocytogenes virulence factor Inlb differ in c-Met binding efficiency and differently affect uptake and survival Listeria in macrophage
FI3063287T3 (fi) Monensiinin käyttö rekombinanttiproteiinien glykosylaation säätelyyn
Ibrahim et al. Bioinformatics Meets Virology: The European Virus Bioinformatics Center’s Second Annual Meeting